Parkinson?s Disease Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Parkinson?s Disease Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinson?s Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinson?s Disease Therapeutics Overall Market Size
2.1 Global Parkinson?s Disease Therapeutics Market Size: 2023 VS 2030
2.2 Global Parkinson?s Disease Therapeutics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Parkinson?s Disease Therapeutics Players in Global Market
3.2 Top Global Parkinson?s Disease Therapeutics Companies Ranked by Revenue
3.3 Global Parkinson?s Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Parkinson?s Disease Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Parkinson?s Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Parkinson?s Disease Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Parkinson?s Disease Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Parkinson?s Disease Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Parkinson?s Disease Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 Transdermal
4.1.4 Subcutaneous
4.1.5 Intestinal Infusion
4.2 By Type - Global Parkinson?s Disease Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Parkinson?s Disease Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Parkinson?s Disease Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Parkinson?s Disease Therapeutics Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Parkinson?s Disease Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Parkinson?s Disease Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Parkinson?s Disease Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Parkinson?s Disease Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Parkinson?s Disease Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Parkinson?s Disease Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Parkinson?s Disease Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Parkinson?s Disease Therapeutics Revenue, 2019-2030
6.3.2 US Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.3.3 Canada Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.3.4 Mexico Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Parkinson?s Disease Therapeutics Revenue, 2019-2030
6.4.2 Germany Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.4.3 France Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.4.4 U.K. Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.4.5 Italy Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.4.6 Russia Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.4.7 Nordic Countries Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.4.8 Benelux Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Parkinson?s Disease Therapeutics Revenue, 2019-2030
6.5.2 China Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.5.3 Japan Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.5.4 South Korea Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.5.5 Southeast Asia Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.5.6 India Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Parkinson?s Disease Therapeutics Revenue, 2019-2030
6.6.2 Brazil Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.6.3 Argentina Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Parkinson?s Disease Therapeutics Revenue, 2019-2030
6.7.2 Turkey Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.7.3 Israel Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.7.4 Saudi Arabia Parkinson?s Disease Therapeutics Market Size, 2019-2030
6.7.5 UAE Parkinson?s Disease Therapeutics Market Size, 2019-2030
7 Parkinson?s Disease Therapeutics Companies Profiles
7.1 Abbvie
7.1.1 Abbvie Company Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Parkinson?s Disease Therapeutics Major Product Offerings
7.1.4 Abbvie Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.1.5 Abbvie Key News & Latest Developments
7.2 Biogen
7.2.1 Biogen Company Summary
7.2.2 Biogen Business Overview
7.2.3 Biogen Parkinson?s Disease Therapeutics Major Product Offerings
7.2.4 Biogen Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Biogen Key News & Latest Developments
7.3 Boehringer Ingelheim GmbH
7.3.1 Boehringer Ingelheim GmbH Company Summary
7.3.2 Boehringer Ingelheim GmbH Business Overview
7.3.3 Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Major Product Offerings
7.3.4 Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.3.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.4 F. Hoffman-La Roche
7.4.1 F. Hoffman-La Roche Company Summary
7.4.2 F. Hoffman-La Roche Business Overview
7.4.3 F. Hoffman-La Roche Parkinson?s Disease Therapeutics Major Product Offerings
7.4.4 F. Hoffman-La Roche Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.4.5 F. Hoffman-La Roche Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Parkinson?s Disease Therapeutics Major Product Offerings
7.5.4 GlaxoSmithKline Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 H. Lundbeck A/S
7.6.1 H. Lundbeck A/S Company Summary
7.6.2 H. Lundbeck A/S Business Overview
7.6.3 H. Lundbeck A/S Parkinson?s Disease Therapeutics Major Product Offerings
7.6.4 H. Lundbeck A/S Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.6.5 H. Lundbeck A/S Key News & Latest Developments
7.7 Impax Labs
7.7.1 Impax Labs Company Summary
7.7.2 Impax Labs Business Overview
7.7.3 Impax Labs Parkinson?s Disease Therapeutics Major Product Offerings
7.7.4 Impax Labs Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Impax Labs Key News & Latest Developments
7.8 Newron Pharmaceuticals SpA
7.8.1 Newron Pharmaceuticals SpA Company Summary
7.8.2 Newron Pharmaceuticals SpA Business Overview
7.8.3 Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Major Product Offerings
7.8.4 Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Newron Pharmaceuticals SpA Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Parkinson?s Disease Therapeutics Major Product Offerings
7.9.4 Novartis AG Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Orion Corporation
7.10.1 Orion Corporation Company Summary
7.10.2 Orion Corporation Business Overview
7.10.3 Orion Corporation Parkinson?s Disease Therapeutics Major Product Offerings
7.10.4 Orion Corporation Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.10.5 Orion Corporation Key News & Latest Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.11.3 Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Major Product Offerings
7.11.4 Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.11.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.12 UCB S.A.
7.12.1 UCB S.A. Company Summary
7.12.2 UCB S.A. Business Overview
7.12.3 UCB S.A. Parkinson?s Disease Therapeutics Major Product Offerings
7.12.4 UCB S.A. Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.12.5 UCB S.A. Key News & Latest Developments
7.13 Livzon Pharmaceutical
7.13.1 Livzon Pharmaceutical Company Summary
7.13.2 Livzon Pharmaceutical Business Overview
7.13.3 Livzon Pharmaceutical Parkinson?s Disease Therapeutics Major Product Offerings
7.13.4 Livzon Pharmaceutical Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.13.5 Livzon Pharmaceutical Key News & Latest Developments
7.14 Haisco Pharmaceutical
7.14.1 Haisco Pharmaceutical Company Summary
7.14.2 Haisco Pharmaceutical Business Overview
7.14.3 Haisco Pharmaceutical Parkinson?s Disease Therapeutics Major Product Offerings
7.14.4 Haisco Pharmaceutical Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.14.5 Haisco Pharmaceutical Key News & Latest Developments
7.15 Jingxin Pharmaceutical
7.15.1 Jingxin Pharmaceutical Company Summary
7.15.2 Jingxin Pharmaceutical Business Overview
7.15.3 Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Major Product Offerings
7.15.4 Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.15.5 Jingxin Pharmaceutical Key News & Latest Developments
7.16 Dongcheng Biochemicals
7.16.1 Dongcheng Biochemicals Company Summary
7.16.2 Dongcheng Biochemicals Business Overview
7.16.3 Dongcheng Biochemicals Parkinson?s Disease Therapeutics Major Product Offerings
7.16.4 Dongcheng Biochemicals Parkinson?s Disease Therapeutics Revenue in Global Market (2019-2024)
7.16.5 Dongcheng Biochemicals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Parkinson?s Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Parkinson?s Disease Therapeutics Market Drivers in Global Market
Table 3. Parkinson?s Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Parkinson?s Disease Therapeutics in Global Market
Table 5. Top Parkinson?s Disease Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Parkinson?s Disease Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Parkinson?s Disease Therapeutics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Parkinson?s Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Parkinson?s Disease Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinson?s Disease Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Parkinson?s Disease Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Parkinson?s Disease Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Parkinson?s Disease Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Parkinson?s Disease Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Parkinson?s Disease Therapeutics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Parkinson?s Disease Therapeutics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2025-2030
Table 30. Abbvie Company Summary
Table 31. Abbvie Parkinson?s Disease Therapeutics Product Offerings
Table 32. Abbvie Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 33. Abbvie Key News & Latest Developments
Table 34. Biogen Company Summary
Table 35. Biogen Parkinson?s Disease Therapeutics Product Offerings
Table 36. Biogen Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 37. Biogen Key News & Latest Developments
Table 38. Boehringer Ingelheim GmbH Company Summary
Table 39. Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Product Offerings
Table 40. Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 41. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 42. F. Hoffman-La Roche Company Summary
Table 43. F. Hoffman-La Roche Parkinson?s Disease Therapeutics Product Offerings
Table 44. F. Hoffman-La Roche Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 45. F. Hoffman-La Roche Key News & Latest Developments
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Parkinson?s Disease Therapeutics Product Offerings
Table 48. GlaxoSmithKline Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. H. Lundbeck A/S Company Summary
Table 51. H. Lundbeck A/S Parkinson?s Disease Therapeutics Product Offerings
Table 52. H. Lundbeck A/S Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 53. H. Lundbeck A/S Key News & Latest Developments
Table 54. Impax Labs Company Summary
Table 55. Impax Labs Parkinson?s Disease Therapeutics Product Offerings
Table 56. Impax Labs Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 57. Impax Labs Key News & Latest Developments
Table 58. Newron Pharmaceuticals SpA Company Summary
Table 59. Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Product Offerings
Table 60. Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 61. Newron Pharmaceuticals SpA Key News & Latest Developments
Table 62. Novartis AG Company Summary
Table 63. Novartis AG Parkinson?s Disease Therapeutics Product Offerings
Table 64. Novartis AG Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 65. Novartis AG Key News & Latest Developments
Table 66. Orion Corporation Company Summary
Table 67. Orion Corporation Parkinson?s Disease Therapeutics Product Offerings
Table 68. Orion Corporation Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 69. Orion Corporation Key News & Latest Developments
Table 70. Teva Pharmaceutical Industries Ltd. Company Summary
Table 71. Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Product Offerings
Table 72. Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 73. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 74. UCB S.A. Company Summary
Table 75. UCB S.A. Parkinson?s Disease Therapeutics Product Offerings
Table 76. UCB S.A. Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 77. UCB S.A. Key News & Latest Developments
Table 78. Livzon Pharmaceutical Company Summary
Table 79. Livzon Pharmaceutical Parkinson?s Disease Therapeutics Product Offerings
Table 80. Livzon Pharmaceutical Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 81. Livzon Pharmaceutical Key News & Latest Developments
Table 82. Haisco Pharmaceutical Company Summary
Table 83. Haisco Pharmaceutical Parkinson?s Disease Therapeutics Product Offerings
Table 84. Haisco Pharmaceutical Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 85. Haisco Pharmaceutical Key News & Latest Developments
Table 86. Jingxin Pharmaceutical Company Summary
Table 87. Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Product Offerings
Table 88. Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 89. Jingxin Pharmaceutical Key News & Latest Developments
Table 90. Dongcheng Biochemicals Company Summary
Table 91. Dongcheng Biochemicals Parkinson?s Disease Therapeutics Product Offerings
Table 92. Dongcheng Biochemicals Parkinson?s Disease Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 93. Dongcheng Biochemicals Key News & Latest Developments
List of Figures
Figure 1. Parkinson?s Disease Therapeutics Segment by Type in 2023
Figure 2. Parkinson?s Disease Therapeutics Segment by Application in 2023
Figure 3. Global Parkinson?s Disease Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Parkinson?s Disease Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Parkinson?s Disease Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Parkinson?s Disease Therapeutics Revenue in 2023
Figure 8. By Type - Global Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 16. US Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 20. Germany Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 21. France Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 28. China Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. India Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 34. Brazil Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Parkinson?s Disease Therapeutics Revenue Market Share, 2019-2030
Figure 37. Turkey Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Parkinson?s Disease Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. Abbvie Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Biogen Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. F. Hoffman-La Roche Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. GlaxoSmithKline Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. H. Lundbeck A/S Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Impax Labs Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Novartis AG Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Orion Corporation Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. UCB S.A. Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Livzon Pharmaceutical Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Haisco Pharmaceutical Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Dongcheng Biochemicals Parkinson?s Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
